RECRUITING

An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and improve health outcomes in AYA with SCD.

Official Title

An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

Quick Facts

Study Start:2020-09-28
Study Completion:2025-02-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04688411

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:12 Years to 21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 12-21 years old
  2. * Any sickle cell disease genotype
  3. * On steady state of hydroxyurea for 2 months
  4. * Own of have access to a smartphone during the study period
  1. * Recent hospitalizations within the past 7 days

Contacts and Locations

Study Contact

Sherif M Badawy, MD, MS
CONTACT
(312) 227-4836
sbadawy@luriechildrens.org
Savannah Winkler, BS
CONTACT
(312) 227-4807
swinkler@luriechildrens.org

Principal Investigator

Sherif M. Badawy, MD, MS
PRINCIPAL_INVESTIGATOR
Ann & Robert H Lurie Children's Hospital of Chicago

Study Locations (Sites)

Ann & Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611
United States

Collaborators and Investigators

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

  • Sherif M. Badawy, MD, MS, PRINCIPAL_INVESTIGATOR, Ann & Robert H Lurie Children's Hospital of Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-09-28
Study Completion Date2025-02-01

Study Record Updates

Study Start Date2020-09-28
Study Completion Date2025-02-01

Terms related to this study

Keywords Provided by Researchers

  • sickle cell disease
  • hydrxoyurea
  • mHealth intervention

Additional Relevant MeSH Terms

  • Sickle Cell Disease
  • Sickle Beta Zero Thalassemia
  • Sickle B+ Thalassemia
  • Sickle Cell Hemoglobin C